Posted on

Graf Acquisition IV : NKGen Biotech Presents Interim Phase I Trial Data at 2023 Alzheimer's Association International Conference – Form 8-K – Marketscreener.com

Graf Acquisition IV : NKGen Biotech Presents Interim Phase I Trial Data at 2023 Alzheimer’s Association International Conference – Form 8-K  Marketscreener.com
Source: Graf Acquisition IV : NKGen Biotech Presents Interim Phase I Trial Data at 2023 Alzheimer’s Association International Conference – Form 8-K – Marketscreener.com

By sf-admin